Member

Cook MyoSite


Cook MyoSite is the industry leader in human muscle cell research and the development of novel approaches to the treatment of muscle related disorders. With over 20 years of experience, Cook MyoSite specializes in the production of primary human skeletal muscle cells (skMDCs) derived from healthy donors as well as individuals with certain neuromuscular diseases and metabolic disorders. Cook MyoSite’s cells are being used worldwide for both basic research as well as development of new therapies and implantable devices for certain muscle related disorders, including volumetric muscle loss (VML). Our Custom Cell Services (CCS) business unit maintains and supplies a large library of well characterized human myoblasts for research and development applications. The CCS group also provides a comprehensive range of development and support offerings, including consultation services, unique donor/tissue sourcing, analytical testing, process development and GMP manufacturing capabilities. Utilizing our extensive background and experience in muscle cell manufacturing and clinical development, Cook MyoSite works closely with academic researchers and industry partners in an effort to accelerate innovation and advances in musculoskeletal and neuromuscular health worldwide.

Industries

Life Science

Nr. of Employees

medium (51-250)

Cook MyoSite


Patents

Methods, substrates, and systems useful for cell seeding of medical grafts

2024-10-22 • US-12121631-B2

View Details

Products

Primary human skeletal muscle-derived cells

Single-donor, characterized primary human skeletal muscle myoblast-like cells for fundamental and disease-specific research. Includes access to donor tissue from both healthy individuals and those with neuromuscular, metabolic, and rare disorders such as myotonic dystrophy, Guillain-Barre syndrome, Marfan syndrome, and Friedrich's ataxia, with robust metadata and clinical history available.

Human fibro-adipogenic progenitor cell preparations

Purified human primary fibro-adipogenic progenitor cells suitable for modeling muscle regeneration, fibrosis, adipogenesis, and disease across multiple donor backgrounds.

Custom muscle cell and media solutions

Tailored products and custom solutions, including procurement of specific donor tissue (healthy or disease), custom lot manufacturing, and unique media formulation.

Cell culture media and supplements

Basal, differentiation, cryopreservation, serum-free, and insulin-free media designed for primary muscle cell growth and differentiation.

Expertise Areas

  • Clinical trial management for cell-based therapies
  • Cellular and regenerative medicine research
  • GMP cell manufacturing
  • Human skeletal muscle and progenitor cell biology
  • Show More (5)

Key Technologies

  • Primary human skeletal muscle cell isolation
  • Autologous muscle-derived cell manufacturing
  • Fibro-adipogenic progenitor cell production
  • Custom cell culture media formulations
  • Show More (6)

Key People

President

Vice President, Regulatory and Scientific Affairs

LinkedIn

Managing Vice President

LinkedIn

News & Updates

Laboratory research services manufactured under an ISO9001:2015 Certified Quality Management System.

Three separate RMAT designations awarded by the FDA for autologous muscle-derived cell therapies in stress urinary incontinence, fecal incontinence, and oropharyngeal dysphagia.

A compilation of peer-reviewed publications related to the muscle-derived cell therapy technology and its research applications.

Discussion of comparative advantages of primary human muscle cells over immortalized cell lines in research applications.

Expert opinions on the application and future of regenerative medicine in the field of urology.

Initiation of participant treatment in a Phase III trial evaluating safety and efficacy of autologous muscle-derived cells for chronic fecal incontinence in women with obstetric anal sphincter injury.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.